Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by Crossref.
Schrader, G D
1991.
The neuroleptic malignant syndrome.
Medical Journal of Australia,
Vol. 154,
Issue. 5,
p.
301.
Adityanjee
1991.
The Myth of Elevated Serum Creatine Phosphokinase Level and Neuroleptic Malignant Syndrome.
British Journal of Psychiatry,
Vol. 158,
Issue. 5,
p.
706.
Caroff, Stanley N
Mann, Stephan C
Lazarus, Arthur
Sullivan, Kenneth
and
MacFadden, Wayne
1991.
Neuroleptic Malignant Syndrome: Diagnostic Issues.
Psychiatric Annals,
Vol. 21,
Issue. 3,
p.
130.
1991.
Catatonia: a contemporary approach.
The Journal of Neuropsychiatry and Clinical Neurosciences,
Vol. 3,
Issue. 3,
p.
334.
Wooduff, P. W. R.
Palazidou, E.
Cranston, I.
Toone, B. K.
Summers, B.
and
Eddleston, A. L. W. F.
1991.
Neoplasia and the neuroleptic malignant syndrome.
Human Psychopharmacology: Clinical and Experimental,
Vol. 6,
Issue. 3,
p.
257.
de Boer, C.
and
Gaete, H. P.
1992.
Neuroleptic Malignant Syndrome and Diabetic Keto-acidosis.
British Journal of Psychiatry,
Vol. 161,
Issue. 6,
p.
856.
Modestin, Jiri
Toffler, Georg
and
Drescher, Joachim P.
1992.
Neuroleptic malignant syndrome: Results of a prospective study.
Psychiatry Research,
Vol. 44,
Issue. 3,
p.
251.
Capellà, Dolors
and
Figueras, Albert
1992.
Vol. 16,
Issue. ,
p.
39.
Otani, K.
Mihara, K.
Kondo, T.
Okada, M.
Kaneko, S.
and
Fukushima, Y.
1992.
Treatment of neuroleptic malignant syndrome with levodopa.
Human Psychopharmacology: Clinical and Experimental,
Vol. 7,
Issue. 3,
p.
217.
Gurrera, Ronald J.
and
Romero, Jorge A.
1992.
Sympathoadrenomedullary activity in the neuroleptic malignant syndrome.
Biological Psychiatry,
Vol. 32,
Issue. 4,
p.
334.
Hosty, Gary
1992.
Neuroleptic malignant syndrome in two sisters.
Irish Journal of Psychological Medicine,
Vol. 9,
Issue. 2,
p.
122.
Gratz, Silvia S.
Levinson, Douglas F.
and
Simpson, George M.
1992.
The treatment and management of neuroleptic malignant syndrome.
Progress in Neuro-Psychopharmacology and Biological Psychiatry,
Vol. 16,
Issue. 4,
p.
425.
Koponen, Hannu J.
Lepola, Ulla M.
and
Leinonen, Esa V.J.
1993.
Neuroleptic malignant syndrome during remoxipride treatment. A case report.
European Neuropsychopharmacology,
Vol. 3,
Issue. 4,
p.
517.
Koponen, Hannu J.
Lepola, Ulla
Leinonen, Esa
and
Paljärvi, Leo
1993.
Normal neuropathological findings after neuroleptic malignant syndrome.
Human Psychopharmacology: Clinical and Experimental,
Vol. 8,
Issue. 3,
p.
217.
Allen, Judith M V
and
Monaghan, Clare E
1993.
Carbon monoxide poisoning and neuroleptic malignant syndrome.
Irish Journal of Psychological Medicine,
Vol. 10,
Issue. 3,
p.
155.
Huckle, Phil
Kellam, Alexander
Williams, Peter
Tanaghow, Amgad
and
Lloyd, Alan
1993.
Do cases of neuroleptic malignant syndrome cluster?.
Irish Journal of Psychological Medicine,
Vol. 10,
Issue. 1,
p.
28.
O'Dwyer, Anne-Marie
and
Sheppard, Noel P.
1993.
The role of creatine kinase in the diagnosis of Neuroleptic Malignant Syndrome.
Psychological Medicine,
Vol. 23,
Issue. 2,
p.
323.
Thornberg, Sheri A.
and
Ereshefsky, Larry
1993.
Neuroleptic Malignant Syndrome Associated With Clozapine Monotherapy.
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy,
Vol. 13,
Issue. 5,
p.
510.
Lloyd, G G
1993.
Acute behaviour disturbances..
Journal of Neurology, Neurosurgery & Psychiatry,
Vol. 56,
Issue. 11,
p.
1149.
Cape, Gavin
1994.
Neuroleptic Malignant Syndrome - A Cautionary Tale and a Surprising Outcome.
British Journal of Psychiatry,
Vol. 164,
Issue. 1,
p.
120.
eLetters
No eLetters have been published for this article.